BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3575313)

  • 1. Ultrastructural differentiation and CEA expression of butyrate-treated human pancreatic carcinoma cells.
    el-Deriny SE; O'Brien MJ; Christensen TG; Kupchik HZ
    Pancreas; 1987; 2(1):25-33. PubMed ID: 3575313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural differentiation of sodium butyrate-treated human pancreatic adenocarcinoma cell lines.
    Mullins TD; Kern HF; Metzgar RS
    Pancreas; 1991 Sep; 6(5):578-87. PubMed ID: 1946315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of sodium butyrate and retinoic acid on growth and CEA production in a series of human colorectal tumor cell lines representing different states of differentiation.
    Niles RM; Wilhelm SA; Thomas P; Zamcheck N
    Cancer Invest; 1988; 6(1):39-45. PubMed ID: 3365571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium butyrate on human breast carcinoma (MCF-7) cellular proliferation, morphology, and CEA production.
    Abe M; Kufe DW
    Breast Cancer Res Treat; 1984; 4(4):269-74. PubMed ID: 6518293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of antigen expression in human and hamster pancreatic cancer cell lines induced by sodium butyrate.
    Corra S; Kazakoff K; Mogaki M; Cano M; Pour PM
    Teratog Carcinog Mutagen; 1993; 13(5):199-215. PubMed ID: 7905674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells.
    Tsao D; Morita A; Bella A; Luu P; Kim YS
    Cancer Res; 1982 Mar; 42(3):1052-8. PubMed ID: 7059970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of pancreatic carcinoma induced by retinoic acid or sodium butyrate: a morphological and molecular analysis of four cell lines.
    Egawa N; Maillet B; VanDamme B; De Grève J; Klöppel G
    Virchows Arch; 1996 Sep; 429(1):59-68. PubMed ID: 8865855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of carcinoembryonic antigen by adenoma and carcinoma derived epithelial cell lines: possible marker of tumour progression and modulation of expression by sodium butyrate.
    Berry RD; Paraskeva C
    Carcinogenesis; 1988 Mar; 9(3):447-50. PubMed ID: 3345582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of carcinoembryonic-antigen-gene expression in human colorectal carcinoma by sodium butyrate.
    Saini K; Steele G; Thomas P
    Biochem J; 1990 Dec; 272(2):541-4. PubMed ID: 2268282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrate induced reduction of tumor cell laminin receptors.
    Bryant G; Haberern C; Rao CN; Liotta LA
    Cancer Res; 1986 Feb; 46(2):807-11. PubMed ID: 2934129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sodium butyrate and dimethylsulfoxide on human pancreatic tumor cell lines.
    McIntyre LJ; Kim YS
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):265-71. PubMed ID: 6200329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
    Ohannesian DW; Lotan D; Lotan R
    Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase in 5'-nucleotidase activity.
    Navarro JM; Olmo N; Turnay J; López-Conejo MT; Lizarbe MA
    Eur J Clin Invest; 1997 Jul; 27(7):620-8. PubMed ID: 9263751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sodium butyrate, a differentiating agent, on cell surface glycoconjugates of a human pancreatic cell line.
    Bloom EJ; Siddiqui B; Hicks JW; Kim YS
    Pancreas; 1989; 4(1):59-64. PubMed ID: 2717602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of carcinoembryonic antigen release by HT-29 colon carcinoma line in the presence of different agents.
    Friedman J; Seger M; Levinsky H; Allalouf D
    Experientia; 1987 Oct; 43(10):1121-2. PubMed ID: 2444456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of differentiated subclones from a human salivary adenocarcinoma cell clone in culture after treatment with sodium butyrate.
    Azuma M; Hayashi Y; Yoshida H; Yanagawa T; Yura Y; Ueno A; Sato M
    Cancer Res; 1986 Feb; 46(2):770-7. PubMed ID: 3000585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular distribution, synthesis, and release of carcinoembryonic antigen in cultured human colon adenocarcinoma cell lines.
    Shi ZR; Tsao D; Kim YS
    Cancer Res; 1983 Sep; 43(9):4045-9. PubMed ID: 6871845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation.
    Mariadason JM; Rickard KL; Barkla DH; Augenlicht LH; Gibson PR
    J Cell Physiol; 2000 Jun; 183(3):347-54. PubMed ID: 10797309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New stable butyrate derivatives alter proliferation and differentiation in human mammary cells.
    Planchon P; Raux H; Magnien V; Ronco G; Villa P; Crépin M; Brouty-Boyé D
    Int J Cancer; 1991 May; 48(3):443-9. PubMed ID: 2040538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in the induction and expression of carcinoembryonic antigen-related antigens in human colon cancer cell lines.
    Toribara NW; Sack TL; Gum JR; Ho SB; Shively JE; Willson JK; Kim YS
    Cancer Res; 1989 Jun; 49(12):3321-7. PubMed ID: 2720685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.